| 
Memorandum
TO:
Medical School
Department Chairs and Administrators
FROM:
Steve A. Goldstein,
Ph.D., Associate Dean for Research and Graduate Studies
William R.
Elger, Executive Director for Administration and Chief Financial
Officer
DATE:
January 21,
2003
RE:
IRB fee for
industrial sponsors
The Medical
School announces an increase in the IRBMED fee charged to industry
sponsors.
For the first
time since 1997, when the fee was introduced, the Medical School
will increase the charge to industrial sponsors for review of protocols
involving human research participants by the Medical School's Institutional
Review Boards. The fee will increase from $1,000 to $1,800.
Sponsored
projects being routed to the Medical School Grants Office will be
expected to carry the new rate as of February 17, 2003. Previously
reviewed proposals, or those undergoing current review, may be grandfathered
into this system. The Medical School Grants Office will make the
determinations for any exceptions to the new fee during this transition.
A review of
peer institutions indicates this increased fee is consistent within
the practices of the group. Industrial sponsors of research involving
human subjects are accustomed to paying fees for IRB review as a
direct cost line item in the study budget.
We will further
communicate this information to the research community via the Biomedical
Research News, E-News, and some targeted e-mail groups.
If you have
any questions about implementation, please contact the Medical School
Grants Office at 763-4272.
Back to the top
|
